Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Voyageur Pharmaceuticals Ltd. (V:VM)

Business Focus: Pharmaceuticals

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for VM within the last 6 months
See all filings within the past 6 months

Company News

May 11, 2020 07:00 ET
Voyageur Secures Exclusive Rights To One Of The Worlds Rarest Pharmaceutical Minerals, Creating A New Era In Carbon Based Drug Development
Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (USA:VYYRF) (the “Company” or “Voyageur”) is pleased to announce it has signed an LOI with an established international mining company (the “Counterparty”) that has developed a low cost method to extract the...
Read full article
Apr 03, 2020 07:04 ET
Voyageur Announces Year-End Audited Financial Statements & MD&A
CALGARY, Alberta – TheNewswire- April 3rd,2020 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (the “Company” or “Voyageur”) (formally Voyageur Minerals Ltd.) is pleased to announce the filing of its 2019 year-end audited Financial Statements and MD&A. The Company's Financial Statements and MD&A are available on SEDAR (
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Jun 15, 20208,101-104,252
May 31, 2020112,353109,528
May 15, 20202,825-4,540
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Voyageur Pharmaceuticals Ltd., formerly Voyageur Minerals Ltd., is an exploration stage pharmaceutical company. The Company is focused on manufacturing mineral based pharmaceutical products. The Company is engaged in the acquisition, exploration and evaluation of pharmaceutical mineral resource properties. It has interests in five mineral properties located in the province of British Colombia, Canada and the state of Utah, United States of America.

See business summary



Search (past week) for $VM.CA VM.V

  • No tweets found